Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental
Gabriella Di Rosa1, Giuseppina Pustorino, Maria Spano
1Department of Medical and Surgical Pediatrics, Unit of Infantile Neuropsychiatry, University Hospital of Messina, Messina, Italy. gabrielladirosa@hotmail.com
Insights
Type I hyperprolinemia (HPI), a genetic disorder from proline oxidase deficiency, is linked to epilepsy and cognitive issues. This study investigates PRODH gene mutations in Italian children with HPI to understand genotype-phenotype correlations.
Area of Science:
- Genetics
- Biochemistry
- Neurology
Background:
- Type I hyperprolinemia (HPI) is an autosomal recessive metabolic disorder.
- It results from a deficiency in the enzyme proline oxidase, encoded by the proline dehydrogenase (PRODH) gene.
- While PRODH mutations' effects on enzyme activity are known, few HPI patients with neurological and behavioral issues have been documented.
Purpose of the Study:
- To screen four Italian children with HPI, epilepsy, mental retardation, and behavioral disorders for PRODH gene mutations.
- To establish a genotype-phenotype correlation in these patients.
- To further understand the clinical spectrum of Type I hyperprolinemia.
Main Methods:
- Genetic screening of the PRODH gene in affected children.
- Analysis of identified mutations for potential functional impact.
- Clinical assessment and correlation with genetic findings.
Main Results:
- Identification of specific PRODH gene mutations in the studied Italian children with HPI.
- Correlation between identified genotypes and the observed phenotypes (epilepsy, cognitive, and behavioral disturbances).
- Insights into the functional consequences of these mutations in vivo.
Conclusions:
- PRODH gene mutations are associated with Type I hyperprolinemia presenting with significant neurological and behavioral comorbidities.
- Genotype-phenotype correlation provides a better understanding of HPI's clinical variability.
- Further research is warranted to elucidate the mechanisms linking proline oxidase deficiency to these complex symptoms.
Abstract:
Type I hyperprolinemia (HPI) is an autosomal recessive disorder caused by proline oxidase deficiency. This enzyme is encoded by the proline dehydrogenase (PRODH) gene on 22q11. The functional consequences of different PRODH mutations on proline oxidase activity have been characterized in vitro. Few patients with HPI with epilepsy and cognitive/behavioral disturbances have been described so far. We screened four Italian children with HPI presenting epilepsy, mental retardation, and behavioral disorders for PRODH gene mutations, and attempted a genotype-phenotype correlation.
More Related Videos
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
09:57Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Related Concept Videos
Inborn Errors of Metabolism
Huntington Disease l: Introduction
Lysosomal Hydrolases
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Alterations in Muscle Tone lll
